11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2
- Product Name
- 11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2
- CAS No.
- 109826-53-1
- Chemical Name
- 11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2
- Synonyms
- BICYCLO PROSTAGLANDIN E2;CGCZPIJMGKLVTQ-PAJBVNRRSA-N;11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2;(Z)-7-[(2,5-Dioxo-4-butyloctahydro-1H-inden)-1-yl]-5-heptenoic acid;5-Heptenoic acid, 7-[(1R,3aS,7aS)-4-butyloctahydro-2,5-dioxo-1H-inden-1-yl]-, (5Z)-
- CBNumber
- CB1128109
- Molecular Formula
- C20H30O4
- Formula Weight
- 334.45
- MOL File
- 109826-53-1.mol
11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2 Property
- Boiling point:
- 510.3±35.0 °C(Predicted)
- Density
- 1.069±0.06 g/cm3(Predicted)
- solubility
- DMF: >25 mg/ml
DMSO: >25 mg/ml
Ethanol: >30 mg/mlPBS (pH 7.2): >1.4 mg/ml - pka
- 4.75±0.10(Predicted)
N-Bromosuccinimide Price
- Product number
- LIP0002488
- Product name
- 11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2
- Purity
- 98.00%
- Packaging
- 10MG
- Price
- $1409.1
- Updated
- 2021/12/16
- Product number
- MT-07608
- Product name
- 11-Deoxy-13,14-dihydro-15-keto-11beta,16chi-cycloprostaglandinE2
- Purity
- 98%
- Packaging
- 0.01g
- Price
- $350
- Updated
- 2021/12/16
11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2 Chemical Properties,Usage,Production
Uses
bicyclo-PGE2 (bicyclo-PGEM) is a stable decomposition product of PGE2 and 13, 14-dihydro-15-ketone PGE2[1].
Definition
ChEBI: Bicyclo-PGE2 is a prostanoid.
References
[1] Mucha I, et al. Separation of 125I-labelled prostanoid derivatives by reversed-phase high-performance liquid chromatography. J Chromatogr. 1989 Dec 8;483:419-26. DOI:10.1016/s0021-9673(01)93144-9
[2] M. HAMBERG B S. On the Metabolism of Prostaglandins E1 and E2 in Man[J]. Journal of Biological Chemistry, 1971, 246 1: 6713-6721. DOI: 10.1016/s0021-9258(19)45905-x
[3] A LEONHARDT. In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis.[J]. British Journal of Dermatology, 1997, 136 3: 337-340.
[4] R C MURPHY G A F. Current approaches to estimation of eicosanoid formation in vivo.[J]. Advances in prostaglandin, thromboxane, and leukotriene research, 1994, 22: 341-348.
[5] E. GRANSTRÖM . Chemical instability of 15-keto-13,14-dihydro-PGE2: The reason for low assay reliability[J]. Prostaglandins, 1980, 19 6: Pages 933-957. DOI: 10.1016/0090-6980(80)90127-6
11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2 Preparation Products And Raw materials
Raw materials
Preparation Products
11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2 Suppliers
- Tel
- 027-59626688 18771149750
- sales@amyjet.com
- Country
- China
- ProdList
- 2917
- Advantage
- 58
- Tel
- 800-364-9897
- sales@caymanchem.com
- Country
- China
- ProdList
- 6838
- Advantage
- 58
- Tel
- 14748676110
- Country
- CHINA
- ProdList
- 112
- Advantage
- 58